Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.
about
Pathological outcomes and strategies to achieve optimal cancer control during robotic radical prostatectomy in Asian-Indian menEmerging critical role of molecular testing in diagnostic genitourinary pathologyMAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerGene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimensPathology in prostate research: optimizing the pathological data.Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcomePositive resection margins may not reflect the true margin in patients undergoing radical prostatectomyPerineural invasion is an independent predictor of outcome in colorectal cancer.Risk Factors for Intraprostatic Incision into Malignant Glands at Radical ProstatectomyTMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis.REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins.International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes.International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling.Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trialHigh-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique.Lymph node-positive prostate cancer: current issues, emerging technology and impact on clinical outcome.Handling of radical prostatectomy specimens.Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting.Variation between specialist uropatholgists in reporting extraprostatic extension after radical prostatectomy.Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies.Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.The association between tumour density and prostate cancer recurrence following radical prostatectomy.Prognosis of prostate cancer with other primary malignancies.Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer.Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance.The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical ProstatectomyProstate cancer diagnosis using epigenetic biomarkers, 3D high-content imaging and probabilistic cell-by-cell classifiers.The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.Does the Prostate Health Index Depend on Tumor Volume?-A Study on 196 Patients after Radical Prostatectomy.Expression of neutral endopeptidase, endothelin-1, and nuclear factor kappa B in prostate cancer: interrelations and associations with prostate-specific antigen recurrence after radical prostatectomy.Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score.Location of positive surgical margin and its association with biochemical recurrence rate do not differ significantly in four different types of radical prostatectomy.The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer.Prognostic significance of histopathological features of extraprostatic extension of prostate cancer.
P2860
Q24635051-38100FA8-7A45-4E04-816C-02C35069DC7BQ27021371-D780ED57-BBB8-4A70-8A1B-811C93663814Q28478930-3331E4CA-23E3-4C37-86DF-D922B2F93388Q33361134-6BB5594F-8A17-4E43-AEA1-0BFE15A08F01Q33747053-7113BC54-D349-4CBF-89CC-1EE40E1F0B66Q33909029-21418444-45C4-4343-B8FF-0693BADC6B57Q34028208-13F137A2-8570-4BB8-A560-608ACC5A8B37Q34293280-62C927D4-DDB5-41F7-B473-6378E3E14F05Q34611646-2720F254-77E9-4E68-91AC-2BB7799C6D85Q35033755-6F8C0208-5D5C-419A-9DD9-5ADBF1E4E810Q36147719-1F462DC0-37C3-4E34-94DB-AFBFFE8D6581Q36235443-8F2CC817-095C-4B16-B26E-704997D74816Q37518609-E85FCFCA-7ACC-45D2-8802-85F370E31894Q37781683-63AC40BC-DE31-4B96-BBFD-7EE52F2F264FQ37785485-E383C3E6-ECC6-426C-B563-81457AF337E6Q37787737-FBFBCE5D-462F-49EB-A098-469C0C1271BAQ37819234-16DF5262-91BA-40EF-9743-265A603A9CE1Q37934734-08185B59-5A55-4D24-B0E9-84DCF383C932Q37934976-9E175B3D-5585-434B-93FB-FD829DB147E3Q37972701-1ACD9B9B-425F-47BE-AE56-BAEDAF9977EBQ38067446-02FA0F71-6714-4C7D-97C8-39F904A079F5Q38384899-E7EE0157-6377-422D-A1A5-4B50764DFE3DQ38916152-8E0A4EFD-7B94-4744-B46E-45BDD5DDBC1BQ39350465-DE6E86B5-51EC-468E-B917-F10705DE2CFEQ39717982-8DED63E6-5B6C-49BF-816C-9BF4038C4316Q39757011-556FBBA0-17F1-4599-BDF8-A7E11ACF8E79Q40708373-E49698FE-93E6-4DCD-8219-381A911ECDD3Q41063995-681C3414-79E4-46BE-8903-752969A6A633Q41120495-77EA80BD-A537-4340-9C18-D0C141DEFB72Q41342281-A4A612F2-5CCD-4D63-AD4E-E6CC3135897CQ41435839-61631B83-93D4-4E88-9F90-04442C462B03Q41837254-46E2E368-C345-4E33-B73A-668C69841C4FQ41847322-B459C40B-D1BF-425C-805F-20AB181BD9C2Q41854285-F9C27307-03B4-4138-A92F-4711B117327DQ42126017-B31658C4-3CF8-4610-994C-9D03008B48B0Q42139633-B63DE900-7107-455B-8832-99AEF0AE0767Q42140991-81841667-7BC2-41B8-969D-6EB775A4DB51Q42614060-25BE56BB-873D-4E74-940C-993B79C4B31AQ43650830-D30141C9-BEF8-4BAE-8581-01AFA9076EB9Q43923266-BD5233DA-5869-45E7-B024-92AC6600ABAC
P2860
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prognostic factors and reporti ...... vic lymphadenectomy specimens.
@ast
Prognostic factors and reporti ...... vic lymphadenectomy specimens.
@en
type
label
Prognostic factors and reporti ...... vic lymphadenectomy specimens.
@ast
Prognostic factors and reporti ...... vic lymphadenectomy specimens.
@en
prefLabel
Prognostic factors and reporti ...... vic lymphadenectomy specimens.
@ast
Prognostic factors and reporti ...... vic lymphadenectomy specimens.
@en
P2093
P2860
P1476
Prognostic factors and reporti ...... vic lymphadenectomy specimens.
@en
P2093
Don Newling
Gregor Mikuz
John R Srigley
Jonathan I Epstein
Lars Egevad
Liliane Boccon-Gibod
Mahul Amin
Peter A Humphrey
Sten Nilsson
Thomas M Wheeler
P2860
P356
10.1080/03008880510030932
P577
2005-05-01T00:00:00Z